Holen Sie sich die Stockscreener-App
34.11
0.12%
-0.04
Handel nachbörslich:
34.11
Schlusskurs vom Vortag:
$34.15
Offen:
$33.86
24-Stunden-Volumen:
184.01K
Relative Volume:
0.29
Marktkapitalisierung:
$1.55B
Einnahmen:
$1.18B
Nettoeinkommen (Verlust:
$2.05M
KGV:
789.58
EPS:
0.0432
Netto-Cashflow:
$66.94M
1W Leistung:
+5.44%
1M Leistung:
-17.41%
6M Leistung:
+11.76%
1J Leistung:
+4.34%
1-Tages-Spanne:
$33.53
$34.48
1-Wochen-Bereich:
$31.75
$34.61
52-Wochen-Spanne:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
34.11 | 1.55B | 1.18B | 2.05M | 66.94M | 0.0432 |
VEEV
Veeva Systems Inc
|
174.64 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
47.30 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.51 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.44 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.63 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Asia Pacific Pharmacy Automation Market Is Going to Boom |• Omnicell • McKesson Corporation - openpr.com
Quarterly Recap: Should value investors consider Omnicell Inc2026 Technicals & Short-Term Swing Trade Alerts - baoquankhu1.vn
Omnicell (OMCL) grants 46,296 RSUs to EVP and COO Nnamdi Njoku - stocktitan.net
Omnicell (OMCL) grants 25,132 RSUs to EVP Corey Manley - stocktitan.net
Omnicell (NASDAQ: OMCL) CEO Randall Lipps receives 90,939-share RSU grant - stocktitan.net
Omnicell (OMCL) CFO receives 37,037 RSU award, holdings reach 69,969 shares - stocktitan.net
Omnicell (OMCL) CAO granted 5,556 RSUs in new equity award - stocktitan.net
Omnicell Inc stock: Steady performer in healthcare tech – buy now? - AD HOC NEWS
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo! Finance Canada
KeyBanc upgrades Omnicell (OMCL) - MSN
Millennium Group (OMCL) discloses 2,288,570 shares, a 5.0% holding - stocktitan.net
Pharmacy Automation Systems Market is expected to hit US$ 12.05 - openPR.com
Omnicell, Inc. Experiences Revision in Its Stock Evaluation Amid Market Volatility - Markets Mojo
Published on: 2026-04-01 04:22:06 - baoquankhu1.vn
Omnicell Inc (OMCL) Stock Price Quote Today & Current Price Chart - Capital.com
Assenagon Asset Management S.A. Has $11.70 Million Stake in Omnicell, Inc. $OMCL - MarketBeat
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; Omnicell (NASDAQ: OMCL) shows 0% stake - Stock Titan
JPMorgan Chase & Co. Has $15.69 Million Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell Q2 2025 Earnings Preview - msn.com
Published on: 2026-03-25 03:49:16 - baoquankhu1.vn
Should You Continue to Hold OMCL Stock in Your Portfolio? - TradingView
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Pharmaceutical Unit Dose Packaging Market Is Going to Boom | AptarGroup Inc. • Omnicell Inc. • Becton - openpr.com
OMCL PE Ratio & Valuation, Is OMCL Overvalued - Intellectia AI
Pharmacy Inventory Management Software Solutions And Cabinets - openPR.com
Update Recap: What chart patterns are forming on Omnicell Inc2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
Medication Therapy Management Market Current Impact to Make Big Changes | CVS Health, Walgreens, Omnicell - openpr.com
Omnicell, Inc. (OMCL): A bull case theory - MSN
Omnicell (NASDAQ:OMCL) EVP Corey Manley Sells 7,405 Shares - MarketBeat
Omnicell (NASDAQ: OMCL) CEO RSUs vest; shares withheld for taxes - Stock Titan
Omnicell (OMCL) COO gains 37,409 shares; 8,456 withheld for taxes - Stock Titan
Omnicell (OMCL) EVP Manley reports PSU vesting, tax withholding and share sale - Stock Titan
Q4 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
OMCL (NASDAQ: OMCL) affiliate sales; 7,405 restricted shares vest on 03/15/2026 - Stock Titan
Benchmark reiterates Omnicell stock rating on product cycle outlook - Investing.com Australia
Benchmark reiterates Omnicell stock rating on product cycle outlook By Investing.com - Investing.com UK
Pier Capital LLC Reduces Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (NASDAQ:OMCL) Rating Increased to Hold at Zacks Research - MarketBeat
Telepharmacy Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Omnicell (OMCL) to Participate in Benchmark's Virtual Meeting on March 11 - GuruFocus
How Omnicell Inc. (OMCL) Affects Rotational Strategy Timing - Stock Traders Daily
Dynamic Technology Lab Private Ltd Acquires 24,738 Shares of Omnicell, Inc. $OMCL - MarketBeat
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Quantbot Technologies LP Purchases Shares of 25,813 Omnicell, Inc. $OMCL - MarketBeat
Pharmacy Repackaging Systems Market Is Going to Boom Rapidly | - openPR.com
Intech Investment Management LLC Sells 135,679 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story - Sahm
Zacks Research Increases Earnings Estimates for Omnicell - MarketBeat
Aug Patterns: Is Omnicell Inc a play on infrastructure spendingGold Moves & High Conviction Investment Ideas - baoquankhu1.vn
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.79%
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):